(NP (NP Enhancing/NN effect/NN) (PP of/IN (NP 17/CD beta-estradiol/NN)) (PP on/IN (NP human/JJ NK/NN cell/NN activity/NN)) ./.)
(S (NP-SBJ-28 (NP The/DT (ADJP in/FW vitro/FW) effect/NN) (PP of/IN (NP 17/CD beta-estradiol/NN)) (PP on/IN (NP NK/NN activity/NN))) (VP was/VBD (VP studied/VBN (NP *-28/-NONE-))) ./.)
(S-COOD (S (NP-SBJ-29 (NP The/DT (NP-COOD (NP proliferation/NN) and/CC (NP NK/NN activity/NN))) (PP of/IN (NP (NP YT-N17/NN) (PRN -LRB-/-LRB- (NP a/DT human/JJ NK-like/JJ cell/NN line/NN) -RRB-/-RRB-)))) (VP were/VBD (VP enhanced/VBN (NP *-29/-NONE-) (PP by/IN (NP-LGS (NP 17/CD beta-estradiol/NN) (PRN -LRB-/-LRB- (NP E2/NN) -RRB-/-RRB-)))))) ,/, and/CC (S (NP-SBJ-30 the/DT enhancement/NN) (VP was/VBD (VP blocked/VBN (NP *-30/-NONE-) (PP by/IN (NP-LGS (NP (NP tamoxifen/NN) (PRN -LRB-/-LRB- (NP Tx/NN) -RRB-/-RRB-)) ,/, (NP (NP an/DT antagonist/NN) (PP of/IN (NP E2/NN)))))))) ./.)
(S (PP On/IN (NP the/DT contrary/NN)) ,/, (NP-SBJ (NP other/JJ steroid/NN hormones/NNS) (PP such/JJ as/IN (NP-COOD (NP Tx/NN) ,/, (NP progesterone/NN) ,/, and/CC (NP testosterone/NN)))) (VP had/VBD (NP no/DT effect/NN)) ./.)
(S (NP-SBJ YT-N17/NN) (VP contained/VBD (NP (NP (NP (NP (ADJP 11.8/CD fmol\/mg/NN) protein/NN) (PP of/IN (NP estrogen/NN receptor/NN))) (PRN -LRB-/-LRB- (NP (NP mean/NN) (PP of/IN (NP two/CD independent/JJ assays/NNS))) -RRB-/-RRB-)) ,/, (NP (NP a/DT value/NN) (SBAR (WHNP-31 which/WDT) (S (NP-SBJ *T*-31/-NONE-) (VP was/VBD (ADJP-PRD (ADJP 5-10-fold/RB higher/JJR) (PP than/IN (NP (NP that/DT) (PP of/IN (NP other/JJ hematopoietic/JJ cell/NN lines/NNS))))))))))) ./.)
(S-COOD (S (NP-SBJ-32 (NP An/DT enhancement/NN) (PP of/IN (NP NK/NN activity/NN)) (PP by/IN (NP E2/NN))) (VP was/VBD (VP (ADVP also/RB) seen/VBN (NP *-32/-NONE-) (PP in/IN (NP (NP large/JJ granular/JJ lymphocytes/NNS) (VP obtained/VBN (NP */-NONE-) (PP from/IN (NP normal/JJ subjects/NNS)))))))) ,/, and/CC (S (NP-SBJ-33 it/PRP) (VP was/VBD (VP (ADVP-TMP again/RB) suppressed/VBN (NP *-33/-NONE-) (PP by/IN (NP-LGS Tx/NN))))) ./.)
(S (NP-SBJ These/DT data/NNS) (VP suggest/VBP (SBAR that/IN (S (NP-SBJ E2/NN) (VP is/VBZ (NP-PRD (NP one/CD) (PP of/IN (NP (NP the/DT activating/VBG factors/NNS) (PP for/IN (NP NK\/LGL/NN cells/NNS))))))))) ./.)
